Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.2950 (-0.92%) ($4.2950 - $4.2950) on Fri. Sep. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.68% (three month average) | RSI | 30 | Latest Price | $4.2950(-0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) VUG(96%) IVW(89%) INDA(87%) ARKG(85%) SPLV(83%) | Factors Impacting ATRA price | ATRA will decline at least -5.34% in a week (0% probabilities). UUP(-31%) TIP(-13%) USO(-6%) BNDX(4%) SHY(7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.34% (StdDev 10.68%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $4.5 | 5 Day Moving Average | $4.14(3.74%) | 10 Day Moving Average | $4.23(1.54%) | 20 Day Moving Average | $4.5(-4.56%) | To recent high | -51.1% | To recent low | 50.4% | Market Cap | $319m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |